| 1 |
33980760 | Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study. | 2022 May 1 |
1 |
| 2 |
34627693 | Impact of high neutrophil-to-lymphocyte ratio on the cardiovascular benefit of PCSK9 inhibitors in familial hypercholesterolemia subjects with atherosclerotic cardiovascular disease: Real-world data from two lipid units. | 2021 Nov 29 |
1 |
| 3 |
34698927 | Monoclonal Antibodies in the Management of Familial Hypercholesterolemia: Focus on PCSK9 and ANGPTL3 Inhibitors. | 2021 Oct 26 |
1 |
| 4 |
34749871 | [Lipids-lowering effects of equol on low density lipoprotein receptor knockout hamsters]. | 2021 Sep |
1 |
| 5 |
30910667 | LDL-cholesterol goal achievement, cardiovascular disease, and attributed risk of Lp(a) in a large cohort of predominantly genetically verified familial hypercholesterolemia. | 2019 Mar - Apr |
1 |
| 6 |
29498875 | [The role of PCSK9-inhibitors and of lipoprotein apheresis in the treatment of homozygous and severe heterozygous familial hypercholesterolemia: A rivalry, or are things quite different?] | Winter 2018 |
1 |
| 7 |
30039543 | Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery disease. | 2018 Aug |
2 |
| 8 |
31331139 | Familial Hypercholesterolemia (FH) Awareness Amongst Physicians in Mumbai, India. | 2018 Jun |
1 |
| 9 |
27460541 | Ezetimibe increases intestinal expression of the LDL receptor gene in dyslipidaemic men with insulin resistance. | 2016 Dec |
3 |
| 10 |
27919346 | Disease control via intensified lipoprotein apheresis in three siblings with familial hypercholesterolemia. | 2016 Nov - Dec |
1 |
| 11 |
27919365 | Longitudinal treatment patterns among US patients with atherosclerotic cardiovascular disease or familial hypercholesterolemia initiating lipid-lowering pharmacotherapy. | 2016 Nov - Dec |
1 |
| 12 |
26115072 | Screening and treatment of familial hypercholesterolemia - Lessons from the past and opportunities for the future (based on the Anitschkow Lecture 2014). | 2015 Aug |
1 |
| 13 |
24314361 | Lowering LDL cholesterol, but not raising LDL receptor activity, by ezetimibe. | 2013 Nov-Dec |
4 |
| 14 |
22196962 | [Use of ezetimibe in the treatment of familial hypercholesterolemia in children and adolescents]. | 2012 Jul |
1 |
| 15 |
22528129 | Pharmacogenetic aspects in familial hypercholesterolemia with the special focus on FHMarburg (FH p.W556R). | 2012 Jun |
5 |
| 16 |
21127699 | Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia. | 2010 Nov 10 |
2 |
| 17 |
19230898 | Ezetimibe treatment of pediatric patients with hypercholesterolemia. | 2009 Jun |
1 |
| 18 |
19694195 | Ezetimibe as monotherapy in the treatment of hypercholesterolemia in children and adolescents. | 2009 Jun |
1 |
| 19 |
17980884 | Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: a randomized trial in healthy men. | 2008 May |
4 |